{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:38:43Z","timestamp":1761183523738,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K16505","17K17068"],"award-info":[{"award-number":["19K16505","17K17068"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18mk0104117j0001"],"award-info":[{"award-number":["18mk0104117j0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jphs.2020.01.010","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T05:54:57Z","timestamp":1580795697000},"page":"56-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of microminipig as a laboratory animal for pharmacological study by analyzing bepridil-induced cardiovascular responses"],"prefix":"10.1016","volume":"143","author":[{"given":"Yoshio","family":"Nunoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2020.01.010_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jphs.2017.02.002","article-title":"Characterization of microminipigs as an in\u00a0vivo experimental model for cardiac safety pharmacology","volume":"133","author":"Matsukura","year":"2017","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2020.01.010_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2131\/jts.42.93","article-title":"Pharmacological characterization of microminipig as a model to assess the drug-induced cardiovascular responses for non-clinical toxicity and\/or safety pharmacology studies","volume":"42","author":"Yokoyama","year":"2017","journal-title":"J\u00a0Toxicol Sci"},{"key":"10.1016\/j.jphs.2020.01.010_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1253\/circj.72.1003","article-title":"Comparison of electropharmacological effects of bepridil and sotalol in halothane-anesthetized dogs","volume":"72","author":"Ishizaka","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jphs.2020.01.010_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1253\/circj.69.44","article-title":"Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial flbrillation","volume":"69","author":"Nakazato","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.jphs.2020.01.010_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2169\/internalmedicine.46.6024","article-title":"Bepridil for drug-refractory ventricular tachyarrhythmias","volume":"46","author":"Izumi","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jphs.2020.01.010_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3565(25)24897-2","article-title":"Bepridil block of cardiac calcium and sodium channels","volume":"237","author":"Yatani","year":"1986","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jphs.2020.01.010_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000085329","article-title":"Voltage-dependent and frequency-independent inhibition of recombinant Cav3.2 T-type Ca2+ channel by bepridil","volume":"74","author":"Uchino","year":"2005","journal-title":"Pharmacology"},{"key":"10.1016\/j.jphs.2020.01.010_bib8","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.bjp.0702959","article-title":"Bepridil differentially inhibits two delayed rectifier K+ currents, IKr and IKs, in Guinea-pig ventricular myocytes","volume":"128","author":"Wang","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2020.01.010_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(01)01381-4","article-title":"Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031","volume":"430","author":"Kobayashi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2020.01.010_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00168656","article-title":"Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje flbres","volume":"339","author":"Berger","year":"1989","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.jphs.2020.01.010_bib11","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/j.1476-5381.1995.tb17237.x","article-title":"SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in Guinea-pig atrial cells","volume":"116","author":"Hara","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2020.01.010_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1254\/jphs.QT-C13","article-title":"QT PRODACT: usability of miniature pigs in safety pharmacology studies: assessment for drug-induced QT Interval prolongation","volume":"99","author":"Kano","year":"2005","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2020.01.010_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jphs.2020.01.010_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1254\/jphs.QT-C12","article-title":"QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans","volume":"99","author":"Omata","year":"2005","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2020.01.010_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2133\/dmpk.24.404","article-title":"Cytochrome P450-dependent drug oxidation activity of liver microsomes from microminipigs, a possible new animal model for humans in non-clinical studies","volume":"24","author":"Murayama","year":"2009","journal-title":"Drug Metabol Pharmacokinet"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:59:07Z","timestamp":1761163147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861320300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1347861320300116"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2020.01.010","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of microminipig as a laboratory animal for pharmacological study by analyzing bepridil-induced cardiovascular responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2020.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}